Have your patients started asking about psychedelic medicines?
Have your patients started asking about psychedelic medicines?
Have your patients started asking about psychedelic medicines?
For decades we’ve seen an increase in mental health concerns - with few effective solutions.
However, that landscape is rapidly changing.
Thanks to a growing body of evidence showing their efficacy against a number of difficult-to-treat mental health conditions, a growing number of cities, including Washington DC, have decriminalized plant-derived psychedelics.
The state of Oregon went a step further and recently voted to legalize the therapeutic use of psilocybin (magic mushrooms).
Are you prepared for when your patients start asking you about psychedelic options?
At the Psychedelic Medicine Association, our mission is to educate primary care providers, therapists, psychiatrists, and other front-line medical workers on the currently-available and soon-to-be-approved psychedelic medicines.
Because the statistics can’t be denied:
- After MDMA-assisted psychotherapy, 68% of subjects with PTSD no longer qualified for the condition at one-year follow-up
- Ketamine has shown rapid antidepressant and anti-suicidal ideation effects
- Psilocybin has demonstrated improvements in major depression palliative care & end of life anxiety.
And those findings are just the beginning. New research findings are coming out regularly that support the use of psychedelic medicines for a number of difficult-to-treat mental and physical conditions.
Patients have suffered long enough with therapeutic options that bring little relief. It’s time we explore this new world of options so we can begin helping them truly heal.
Get up to speed on psychedelic medicine with our FREE introductory guide.
you'll discover
- Which psychedelic substances are becoming medicines?
- What does the research landscape look like?
- What does the FDA think about Psychedelic medicines?
- What is the legal status of psychedelic medicines?